Clincosm LogoSign in Get a demo

Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

Not yet recruiting
  • Non-hodgkin Lymphoma
  • +9 more
  • CD79b-19 CAR T cells
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 6, 2023

Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

Recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • Milan, Italy
      Ospedale San Raffaele
    Aug 29, 2023

    Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • +5 more
    • La Jolla, California
    • +7 more
    Aug 25, 2023

    Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

    Not yet recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • +5 more
    • Boston, Massachusetts
    • +1 more
    Jun 28, 2023

    Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial in

    Not yet recruiting
    • Classical Hodgkin Lymphoma
    • +2 more
    • Lifestyles Implemented-Survivorship Care Plan (LS-SCP)
    • Ancona, Italy
    • +39 more
    Jun 28, 2023

    CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma

    Active, not recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • DISEASE
    • (no location specified)
    May 4, 2023

    Large B-cell Lymphoma, DLBCL, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial (Epcoritamab)

    Available
    • Large B-cell Lymphoma
    • +4 more
    • Epcoritamab
    • (no location specified)
    Feb 16, 2023

    Hodgkin's Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial in Worldwide (Pembrolizumab)

    Active, not recruiting
    • Hodgkin's Lymphoma
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • Pembrolizumab
    • Torrance, California
    • +26 more
    Oct 20, 2022

    Anaplastic Large Cell Lymphoma, Peripheral T Cell Lymphoma, Extranodal NK/T-cell Lymphoma Trial in Duarte, Nashville, Houston

    Active, not recruiting
    • Anaplastic Large Cell Lymphoma
    • +4 more
    • Duarte, California
    • +3 more
    Jul 21, 2022

    Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) Trial in Milwaukee (8/12-Day

    Recruiting
    • Non Hodgkin Lymphoma (NHL)
    • +6 more
    • 8/12-Day Production of Car-T Cells
    • +2 more
    • Milwaukee, Wisconsin
      Medical College of Wisconsin and Froedtert Hospital
    Jul 1, 2022

    Diffuse Large-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL) Trial in

    Recruiting
    • Diffuse Large-Cell Lymphoma
    • +3 more
    • Pneumococcal conjugate vaccine (PCV13)
    • CD19 targeted CAR T Cell Therapy
    • Tampa, Florida
      Moffitt Cancer Center
    May 31, 2022

    Bio-CAR-T BS Study

    Recruiting
    • Diffuse Large B Cell Lymphoma (DLBCL)
    • +2 more
      • Brescia, Italy
        ASST Spedali Civili di Brescia
      May 5, 2022

      CAR T Cell Therapy Related Cardiovascular Outcomes

      Recruiting
      • Cardiovascular Diseases
      • +7 more
        • London, United Kingdom
          University College London Hospitals
        Nov 18, 2021

        Relapsed Large B-cell Lymphoma, Refractory Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL) Trial in Seoul (CRC01,

        Recruiting
        • Relapsed Large B-cell Lymphoma
        • +5 more
        • CRC01
        • +2 more
        • Seoul, Korea, Republic of
          Samsung Medical Center
        Apr 29, 2021

        Primary Mediastinal Large B-Cell Lymphoma (PMBCL) Trial in China (LP002)

        Not yet recruiting
        • Primary Mediastinal Large B-Cell Lymphoma (PMBCL)
        • Beijing, Beijing, China
        • +6 more
        Oct 19, 2020